18,691
Views
90
CrossRef citations to date
0
Altmetric
Review Article

The pharmacology, toxicology and potential applications of arecoline: a review

, , , &
Pages 2753-2760 | Received 23 Jun 2015, Accepted 26 Feb 2016, Published online: 05 Apr 2016

References

  • Arakeri G, Brennan PA. 2013. Oral submucous fibrosis: an overview of the aetiology, pathogenesis, classification, and principles of management. Br J Oral Maxillofac Surg. 51:587–593.
  • Bales A, Peterson MJ, Ojha S, Upadhaya K, Adhikari B, Barrett B. 2009. Associations between betel nut (Areca catechu) and symptoms of schizophrenia among patients in Nepal: a longitudinal study. Psychiatry Res. 169:203–211.
  • Cai ZY, Li YC, Li LH, Chen ZG. 2012. Analysis of arecoline in Semen Arecae decoction pieces by microchip capillary electrophoresis with contactless conductivity detection. J Pharmaceut Anal. 2:356–360.
  • Calogero AE, Kamilaris TC, Gomez MT, Johnson EO, Tartaglia ME, Gold PW, Chrousos GP. 1989. The muscarinic cholinergic agonist arecoline stimulates the rat hypothalamic-pituitary-adrenal axis through a centrally-mediated corticotropin-releasing hormone-dependent mechanism. Endocrinol. 125:2445–2453.
  • Chandra JN, Malviya M, Sadashiva CT, Subhash MN, Rangappa KS. 2008. Effect of novel arecoline thiazolidinones as muscarinic receptor 1 agonist in Alzheimer's dementia models. Neurochem Int. 52:376–383.
  • Chang BE, Liao MH, Kuo MY, Chen CH. 2004. Developmental toxicity of arecoline, the major alkaloid in betel nuts, in zebrafish embryos. Birth Defects Res A Clin Mol Teratol. 70:28–36.
  • Chang MC, Ho YS, Lee PH, Chan CP, Lee JJ, Hahn LJ, Wang YJ, Jeng JH. 2001. Areca nut extract and arecoline induced the cell cycle arrest but not apoptosis of cultured oral KB epithelial cells: association of glutathione, reactive oxygen species and mitochondrial membrane potential. Carcinogenesis. 22:1527–1535.
  • Chang NW, Pei RJ, Tseng HC, Yeh KT, Chan HC, Lee MR, Lin C, Hsieh WT, Kao MC, Tsai MH, et al. 2010. Co-treating with arecoline and 4-nitroquinoline 1-oxide to establish a mouse model mimicking oral tumorigenesis. Chem Biol Interact. 183:231–237.
  • Chang YC, Tsai CH, Lai YL, Yu CC, Chi WY, Li JJ, Chang WW. 2014. Arecoline-induced myofibroblast transdifferentiation from human buccal mucosal fibroblasts is mediated by ZEB1. J Cell Mol Med. 18:698–708.
  • Chang YF, Liu TY, Liu ST. 2013. Arecoline inhibits and destabilizes agrin-induced acetylcholine receptor cluster formation in C2C12 myotubes. Food Chem Toxicol. 60:391–396.
  • Chatterjee A, Deb S. 1999. Genotoxic effect of arecoline given either by the peritoneal or oral route in murine bone marrow cells and the influence of N-acetylcysteine. Cancer Lett. 139:23–31.
  • Chen DM, Mu SF, Wang H. 2002. Antithrombosis through activating endothelial target for acetylcholine and its molecular mechanism. Chin Pharmacol Bull. 18:527–531.
  • Chen PH, Huang B, Shieh TY, Wang YH, Chen YK, Wu JH, Huang JH, Chen CC, Lee KW. 2014. The influence of monoamine oxidase variants on the risk of betel quid-associated oral and pharyngeal cancer. Sci World J. 2014:183548. Available from: http://dx.doi.org/10.1155/2014/183548.
  • Chen YJ, Chang LS. 2012. Arecoline-induced death of human leukemia K562 cells is associated with surface up-modulation of TNFR2. J Cell Physiol. 227:2240–2251.
  • Cheng SJ, Ko HH, Cheng SL, Lee JJ, Chen HM, Chang HH, Kok SH, Kuo MY, Chiang CP. 2013. Arecoline-stimulated placenta growth factor production in gingival epithelial cells: modulation by curcumin. Oral Dis. 19:513–518.
  • Chou WW, Guh JY, Tsai JF, Hwang CC, Chen HC, Huang JS, Yang YL, Hung WC, Chuang LY. 2008. Arecoline-induced growth arrest and p21WAF1 expression are dependent on p53 in rat hepatocytes. Toxicology. 243:1–10.
  • Chou WW, Guh JY, Tsai JF, Hwang CC, Chiou SJ, Chuang LY. 2009. Arecoline-induced phosphorylated p53 and p21(WAF1) protein expression is dependent on ATM/ATR and phosphatidylinositol-3-kinase in clone-9 cells. J Cell Biochem. 107:408–417.
  • Dasgupta R, Saha I, Pal S, Bhattacharyya A, Sa G, Nag TC, Das T, Maiti BR. 2006. Immunosuppression, hepatotoxicity and depression of antioxidant status by arecoline in albino mice. Toxicology. 227:94–104.
  • Dasgupta R, Chatterji U, Nag TC, Chaudhuri-Sengupta S, Nag D, Maiti BR. 2010. Ultrastructural and hormonal modulations of the thyroid gland following arecoline treatment in albino mice. Mol Cell Endocrinol. 319:1–7.
  • Dave BJ, Trivedi AH, Adhvaryu SG. 1992. In vitro genotoxic effects of areca nut extract and arecoline. J Cancer Res Clin Oncol. 118:283–288.
  • Deng YT, Chang JZ, Yeh CC, Cheng SJ, Kuo MY. 2011. Arecoline stimulated Cyr61 production in human gingival epithelial cells: inhibition by lovastatin. Oral Oncol. 47:256–261.
  • Duan Z, Wang H. 2006. Regulation effect of arecoline on excess expression of adhesive molecules in endothelial cells injuried with high concentration of d-glucose. Chin J Clin Pharmacol Ther. 11:27–31.
  • Du ZM, Wan XX, Wu AC, Chen YY. 1999. Effect of arecoline on spontaneous peristalsis of isolated ileum. J PLA Jun Cil Med. 27:87–88.
  • Editorial Committee of Chinese Pharmacopoeia (2010). Chinese Pharmacopoeia (2010 edn.). China Medical Science and Technology Press: Beijing: p. 342–343.
  • Feng Q, Li GL, Yang Y, Gao J. 1999. Studies on the increasing effect componets of mollusicicides in nut of Areca catechu. J Chin Med Mater. 22:572–574.
  • Garg A, Chaturvedi P, Gupta PC. 2014. A review of the systemic adverse effects of areca nut or betel nut. Indian J Med Paediatr Oncol. 35:3–9.
  • Goto H, Tanaka N, Tanigawa K, Shimada Y, Terasawa T. 1997. Endothelium-dependent vasodilator effect of extract prepared from the seeds of Areca catechu on isolated rat aorta. Phytother Res. 11:457–459.
  • Han R, Sun Y, Li J, Liang J. 2005. Effects of arecoline on morphine-induced behavioral sensitization in mice. Chin J Drug Depend. 14:197–202.
  • Haque MF, Meghji S, Khitab U, Harris M. 2000. Oral submucous fibrosis patients have altered levels of cytokine production. J Oral Pathol Med. 29:123–128.
  • Holdsworth DK, Jones RA, Self R. 1998. Volatile alkaloids from Areca catechu. Phytochemistry. 48:581–582.
  • Hosein M, Mohiuddin S, Fatima N. 2015. Association between grading of oral submucous fibrosis with frequency and consumption of areca nut and its derivatives in a wide age group: a multi-centric cross sectional study from Karachi, Pakistan. J Cancer Prev. 20:216–222.
  • Hsu HF, Tsou TC, Chao HR, Shy CG, Kuo YT, Tsai FY, Yeh SC, Ko YC. 2010. Effects of arecoline on adipogenesis, lipolysis, and glucose uptake of adipocytes-A possible role of betel-quid chewing in metabolic syndrome. Toxicol Appl Pharmacol. 245:370–377.
  • Hu YJ, Jian XC. 2007. The role of epithelial-mesenchymal transition in oral squamous cell carcinoma and oral submucous fibrosis. Clin Chim Acta. 383:51–56.
  • Huang JL, McLeish MJ. 1989. High-performance liquid chromatographic determination of the alkaloids in betel nut. J Chromatogr A. 475:447–450.
  • Huang LW, Hsieh BS, Cheng HL, Hu YC, Chang WT, Chang KL. 2012. Arecoline decreases interleukin-6 production and induces apoptosis and cell cycle arrest in human basal cell carcinoma cells. Toxicol Appl Pharmacol. 258:199–207.
  • Hung TC, Huang LW, Su SJ, Hsieh BS, Cheng HL, Hu YC, Chen YH, Hwang CC, Chang KL. 2011. Hemeoxygenase-1 expression in response to arecoline-induced oxidative stress in human umbilical vein endothelial cells. Int J Cardiol. 151:187–194.
  • Jeng JH, Wang YJ, Chiang BL, Lee PH, Chan CP, Ho YS, Wang TM, Lee JJ, Hahn LJ, Chang MC. 2003. Roles of keratinocyte inflammation in oral cancer: regulating the prostaglandin E2, interleukin-6 and TNF-alpha production of oral epithelial cells by areca nut extract and arecoline. Carcinogenesis. 24:1301–1315.
  • Johnston GA, Krogsgaard-Larsen P, Stephanson A. 1975. Betel nut constituents as inhibitors of gamma-aminobutyric acid uptake. Nature. 258:627–628.
  • Kumpawat K, Deb S, Ray S, Chatterjee A. 2003. Genotoxic effect of raw betel-nut extract in relation to endogenous glutathione levels and its mechanism of action in mammalian cells. Mutat Res. 538:1–12.
  • Lai YL, Lin JC, Yang SF, Liu TY, Hung SL. 2007. Areca nut extracts reduce the intracellular reactive oxygen species and release of myeloperoxidase by human polymorphonuclear leukocytes. J Periodont Res. 42:69–76.
  • Lee SS, Tsai CH, Tsai LL, Chou MC, Chou MY, Chang YC. 2012. β-Catenin expression in areca quid chewing-associated oral squamous cell carcinomas and upregulated by arecoline in human oral epithelial cells. J Formos Med Assoc. 111:194–200.
  • Lee SS, Tsai CH, Yu CC, Chang YC. 2013. Elevated snail expression mediates tumor progression in areca quid chewing-associated oral squamous cell carcinoma via reactive oxygen species. PLoS One. 8:e67985
  • Li GL, Feng Q, Yang Y, Gao J. 2000. [Studies on the effect-increasing components for molluscacides in nut of Areca catech L]. Zhongguo Zhong Yao Za Zhi. 25:160–162.
  • Lim DY, Kim IS. 2006. Arecoline inhibits catecholamine release from perfused rat adrenal gland. Acta Pharmacol Sin. 27:71–79.
  • Ling HY, Wang G, Zhang W, Li X, Zhou SH, Hu B. 2012. Arecoline improves vascular endothelial function in high fructose-fed rats via increasing cystathionine-γ-lyase expression and activating K(ATP) channels. Acta Pharmacol Sin. 33:1023–1029.
  • Liu ST, Young GC, Lee YC, Chang YF. 2011. A preliminary report on the toxicity of arecoline on early pregnancy in mice. Food Chem Toxicol. 49:144–148.
  • Luo SS, Zhang HD, Liu XL, Zhu L. 2010. Study on antimicrobial activity of arecoline from betel nut in vitro. Inno Edit Farm Prod Proc. 10:47–50.
  • Maiese K, Holloway HH, Larson DM, Soncrant TT. 1994. Effect of acute and chronic arecoline treatment on cerebral metabolism and blood flow in the conscious rat. Brain Res. 641:65–75.
  • Mujumdar AM, Kapadi AH, Pendse GS. 1979. Chemistry and pharmacology of betel nut Areca catechu Linn. J Plantation Crops. 7:69–92.
  • Ni YD, Wang JH, Wang RJ. 2004. Comparative study of the effect of areca nut and arecoline on gastrointestinal motility. Pharmacol Clin Chin Mate Med. 20:11–12.
  • Ono M, Minamoto Y, Shibata S, Watanabe S. 1995. Attenuating effect of arecoline and physostigmine on an impairment of mealtime-associated activity rhythm in old rats. Physiol Behav. 57:189–191.
  • Peng W, Liu YJ, Wu N, Sun T, He XY, Gao YX, Wu CJ. 2015a. Areca catechu L. (Arecaceae): a review of its traditional uses, botany, phytochemistry, pharmacology and toxicology. J Ethnopharmacol. 164:340–356.
  • Peng W, Liu YJ, Zhao CB, Huang XS, Wu N, Hu MB, Xie DS, Wu CJ. 2015b. In silico assessment of drug-like properties of alkaloids from Areca catechu L nut. Trop J Pharm Res. 14:635–639.
  • Prabhu RV, Prabhu V, Chatra L, Shenai P, Suvarna N, Dandekeri S. 2014. Areca nut and its role in oral submucous fibrosis. J Clin Exp Dent. 6:e569–575.
  • Qi Z, Yao Q, Wang G, Zhang W, Zhou S, Ling H, Hu B. 2010. Effect of arecoline on PDX-1 mRNA expression in rats with type 2 diabetes meilitus. J Int Pathol Clin Med. 30:14–19.
  • Rangappa KS. 2009. Muscarinic Receptor 1 agonist activity of novel arecoline derivatives in Alzheimer’s dementia models. Alzheimers Dement. 5:243.
  • Risch SC, Janowsky DS, Siever LJ, Judd LJ, Rausch JL, Huey LY, Beckman KA, Cohen RM, Murphy DL. 1982. Correlated cholinomimetic-stimulated beta-endorphin and prolactin release in humans. Peptides 3:319–322.
  • Saikia JR, Schneeweiss FH, Sharan RN. 1999. Arecoline-induced changes of poly-ADP-ribosylation of cellular proteins and its influence on chromatin organization. Cancer Lett. 139:59–65.
  • Saha I, Chatterji U, Chaudhuri-Sengupta S, Nag TC, Nag D, Banerjee S, Maiti BR. 2007. Ultrastructural and hormonal changes in the pineal-testicular axis following arecoline administration in rats. J Exp Zool A Ecol Genet Physiol. 307:187–198.
  • Senn M, Baiwog F, Winmai J, Mueller I, Rogerson S, Senn N. 2009. Betel nut chewing during pregnancy, Madang province, Papua New Guinea. Drug Alcohol Depend. 105:126–131.
  • Shan LM, Zhang JC, Zhao YL, Cui WY, Wang H. 2004. Molecular mechanisms for arecoline against atherosclerosis. Chin Pharmacol Bull. 20:146–149.
  • Shih YT, Chen PS, Wu CH, Tseng YT, Wu YC, Lo YC. 2010. Arecoline, a major alkaloid of the areca nut, causes neurotoxicity through enhancement of oxidative stress and suppression of the antioxidant protective system. Free Radic Biol Med. 49:1471–1479.
  • Shirname LP, Menon MM, Nair J, Bhide SV. 1983. Correlation of mutagenicity and tumorigenicity of betel quid and its ingredients. Nutr Cancer. 5:87–91.
  • Shirname LP, Menon MM, Bhide SV. 1984. Mutagenicity of betel quid and its ingredients using mammalian test systems. Carcinogenesis. 5:501–503.
  • Si CF, Wei MX, Kyoshi N. 2004. A study of the effects of arecaline hydrobromide on the dispersed colonic smooth muscle cells in tats. Shanghai J Trad Chin Med. 38:48–50.
  • Soncrant TT, Holloway HW, Greig NH, Rapoport SI. 1989. Regional brain metabolic responsivity to the muscarinic cholinergic agonist arecoline is similar in young and aged Fischer-344 rats. Brain Res. 487:255–266.
  • Sullivan RJ, Allen JS, Otto C, Tiobech J, Nero K. 2000. Effects of chewing betel nut (Areca catechu) on the symptoms of people with schizophrenia in Palau, Micronesia. Br J Psychiatry. 177:174–178.
  • Sun YP, Han R, Luo J, Chen F, Liang JH. 2005. Effects of arecoline on central suppression in mice treated acutely with ethanol. Chin J Drug Depend. 14:333–337.
  • Sun YP, Liu Q, Luo J, Guo P, Chen F, Lawrence AJ, Liang JH. 2010. Systemic administration of arecoline reduces ethanol-induced sleeping through activation of central muscarinic receptor in mice. Alcohol Clin Exp Res. 34:150–157.
  • Thangjam GS, Agarwal P, Khan I, Verma UP, Balapure AK, Rao SG, Kondaiah P. 2009. Transglutaminase-2 regulation by arecoline in gingival fibroblasts. J Dent Res. 88:170–175.
  • Thangjam GS, Kondaiah P. 2009. Regulation of oxidative-stress responsive genes by arecoline in human keratinocytes. J. Periodont. Res. 44:673–682.
  • Tilakaratne WM, Klinikowski MF, Saku T, Peters TJ, Warnakulasuriya S. 2006. Oral submucous fibrosis: review on aetiology and pathogenesis. Oral Oncol. 42:561–568.
  • Tsai CH, Yang SF, Lee SS, Chang YC. 2009. Augmented heme oxygenase-1 expression in areca quid chewing-associated oral submucous fibrosis. Oral Dis. 15:281–286.
  • Tsai YS, Lee KW, Huang JL, Liu YS, Juo SH, Kuo WR, Chang JG, Lin CS, Jong YJ. 2008. Arecoline, a major alkaloid of areca nut, inhibits p53, represses DNA repair, and triggers DNA damage response in human epithelial cells. Toxicology. 249:230–237.
  • Ullah M, Cox S, Kelly E, Boadle R, Zoellner H. 2014. Arecoline is cytotoxic for human endothelial cells. J Oral Pathol Med. 43:761–769.
  • Utsunomiya H, Tilakaratne WM, Oshiro K, Maruyama S, Suzuki M, Ida-Yonemochi H, Cheng J, Saku T. 2005. Extracellular matrix remodeling in oral submucous fibrosis: its stage-specific modes revealed by immunohistochemistry and in situ hybridization. J Oral Pathol Med. 34:498–507.
  • Wang CK, Peng CH. 1996. The mutagenicities of alkaloids and N-nitrosoguvacoline from betel quid. Mutat Res. 360:165–171.
  • Wang CK, Lee WH, Peng CH. 1997. Contents of phenolics and alkaloids in Areca catechu Linn. during maturation. J Agric Food Chem. 45:1185–1188.
  • Wei X, Zhang J, Niu J, Zhou X, Li J, Li B. 2015. Evaluation of arecoline hydrobromide toxicity after a 14-day repeated oral administration in wistar rats. PLoS One. 10:e0120165.
  • Xia L, Tian-You L, Yi-Jun G, Dong-Sheng T, Wen-Hui L. 2009. Arecoline and oral keratinocytes may affect the collagen metabolism of fibroblasts. J Oral Pathol Med. 38:422–426.
  • Xiao BM, Xiao NQ, Peng MJ, Gong LM, Li C, Lin LM. 2013. Research on effects of arecoline on refreshing and acute toxicity test. Chin Mod Med. 20:14–16.
  • Wang SW, Hwang GS, Chen TJ, Wang PS. 2008. Effects of arecoline on testosterone release in rats. Am J Physiol Endocrinol Metab. 295:E497–504.
  • Yang YY, Koh LW, Tsai JH, Tsai CH, Wong EF, Lin SJ, Yang CC. 2004. Involvement of viral and chemical factors with oral cancer in Taiwan. Jpn J Clin Oncol. 34:176–183.
  • Yao WX, Xia GJ, Li Y, Fu LY, Deng JP, Wu SY, Wang SL. 2001. Concentration effect relationship of arecoline on rat portal vein and calcium channel current in guinea pig ventricular myocytes. Chin J Parasit Dis Con. 14:139–141.
  • Yao Q, Qi Z, Wang G, Zhang W, Zhou S, Ling H, Hu B. 2009. Arecoline improved glucose and lipid metabolism in type 2 diabetic rats. Chin Pharmacol Bull. 25:1477–1481.
  • Yi LJ, Liang NX, Tian L, Zhang CY, Wei MX. 2006. Effects of arecoline hydrobromide at different concentration on calcium mobilization in cultured smooth muscle cells of rat clone. Chin J Integr Trad Western Med Dig. 14:75–78.
  • Zha C, Chen G, Wu M. 1990. The role of Magnolia officinalis Rehd et Wils and betel nut on Fasciola hepatica in vitro. J Nanjing Uni Trad Chin Med. 6:266–269.
  • Zhao WA, Li ZM, Wang BX. 2003. Morphological observation of semen areca and white pepper against cysticercus cellulosae in vitro. Modern J Integr Trad Chin Western Med. 12:237–238.
  • Zhang W, Zhou SH, Ling HY, Yao QX, Qi ZQ, Wang G, Hu B. 2009. Areeoline repressed inflammation factor expression of maerophages stimulated by oxidized low density lipoprotein and its mechanism. Chin J Arteriosclerosis. 17:269–271.
  • Zheng L, Jian X, Guo F, Li N1, Jiang C, Yin P, Min AJ, Huang L. 2015. miR-203 inhibits arecoline-induced epithelial-mesenchymal transition by regulating secreted frizzled-related protein 4 and transmembrane-4 L six family member 1 in oral submucous fibrosis. Oncol Rep. 33:2753–2760.
  • Zheng ZH. 1999. Modern research and application of traditional Chinese medicine. Beijing: Academic Press, p. 4565–4583.
  • Zhou XZ, Zhang JY, Zhao CY, Li JS, Zhang ZF, Li JY, Wei XJ, Niu JR, Wang L. 2007. The study of arecoline hydrobromide's time-effect and dose-effect relationship on propulsive ratio of mice's small intestine. Chin J Vet Drug. 41:28–30.
  • Zhou J, Sun Q, Yang Z, Zhang J. 2014. The hepatotoxicity and testicular toxicity induced by arecoline in mice and protective effects of vitamins C and E. Korean J Physiol Pharmacol. 18:143–148.
  • Zou XH, Li C, Han LP, Jiang LL, Wei S, Chen ZH. 2013. Experimental study on increasing toxicity of Areca catechu and Artemisia annua together. Lishizhen Med Mater Med Res. 24:2608–2609.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.